We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Amgen Terminates Co-Development of Brodalumab with AstraZeneca

News   May 27, 2015

 
Amgen Terminates Co-Development of Brodalumab with AstraZeneca
 
 
Advertisement
 

RELATED ARTICLES

Study Investigates Racial Disparities in Clinical Trial Recruitment

News

Scientists are increasingly turning to electronic-based recruitment methods to encourage participation in clinical trials. Little is known about how this use of technology compares to more traditional clinical trial recruitment strategies, and some researchers worry that an overreliance on technology has the potential to exclude an eligible and interested diverse participant population.

READ MORE

How Giant Spider Venom Might Help Sufferers of Irritable Bowel Syndrome

News

Molecules from the venom of one of the world’s largest spiders could help a team of Institute for Molecular Bioscience-led researchers tailor pain blockers for people with irritable bowel syndrome (IBS).

READ MORE

Dual CAR T Cell Immunotherapy Fights HIV Infection in Humanized Mice

News

A recent study published in the journal Nature Medicine describes a new Dual CAR T cell immunotherapy that can help fight HIV infection.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE